Related Experiment Video
Updated: May 25, 2026
10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
Denis Burkitt and the African lymphoma
1INCTR AISBL, 642 rue Engeland, 1180 Brussels, Belgium.
Ecancermedicalscience
|January 26, 2012
Summary
Burkitt lymphoma research has advanced understanding of lymphomas, but disparities in treatment access persist. Modern techniques are needed to address new questions about this cancer, particularly in resource-limited regions.
Area of Science:
- Oncology
- Epidemiology
- Immunology
Background:
- Burkitt lymphoma serves as a crucial model for understanding lymphoma development and treatment.
- Historical research in Africa highlighted disparities in outcomes compared to developed nations.
- Despite advances, significant challenges remain in managing Burkitt lymphoma, especially in resource-limited settings.
Purpose of the Study:
- To re-evaluate long-standing questions about Burkitt lymphoma using contemporary scientific methods.
- To explore novel questions informed by current knowledge of immunology and molecular oncology.
- To advocate for improved treatment access and outcomes for Burkitt lymphoma patients globally.
Main Methods:
- Review of historical epidemiological data.
- Application of modern molecular biology techniques.
- Comparative analysis of treatment outcomes across different healthcare settings.
Main Results:
- Burkitt lymphoma research has significantly contributed to understanding cancer biology and treatment strategies.
- A persistent gap in survival rates exists between high-income and low-income countries.
- Modern approaches offer new avenues for investigating the disease's complexities.
Conclusions:
- Continued research is essential to address the remaining knowledge gaps in Burkitt lymphoma.
- Efforts must focus on bridging the treatment disparity for affected children worldwide.
- Integrating advanced techniques with historical insights will drive future progress in lymphoma research.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...